BRISTOL MYERS SQUIBB CO
BMY
53 insider filings · Latest: Oct 2, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Sep 10 8:37 PM | Cristian MassacesiEVP,Chief Med Offr,Head of Dev | Sale | 6,249 | $64.57 | $403.5K | 18,748(D) | View → |
| Sep 9, 2026 | Sep 9 2:27 PM | Massacesi Cristian | Proposed Sale | 6,249 | $64.57 | $403.5K | — | View → |
| Aug 25, 2026 | Aug 26 8:17 PM | Phil M HolzerSVP and Controller | Sale | 500 | $67.50 | $33.8K | 16,862(D) | View → |
| Aug 25, 2026 | Aug 25 3:03 PM | Holzer Phil M | Proposed Sale | 500 | $67.50 | $33.8K | — | View → |
| Apr 1, 2026 | Apr 2 8:29 PM | David V ElkinsEVP, Chief Financial Officer | Sale | 30,000 | $61.67 | $1.9M | 159,248(D) | View → |
| Apr 1, 2026 | Apr 1 8:32 PM | Elkins David V | Proposed Sale | 30,000 | $61.69 | $1.9M | — | View → |
| Sep 2, 2025 | Sep 2 3:16 PM | Elkins David V | Proposed Sale | 56,000 | $47.30 | $2.6M | — | View → |
| Nov 4, 2024 | Nov 4 4:20 PM | Holzer Phil M | Proposed Sale | 700 | $55.62 | $38.9K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | Apr 2 8:26 PM | Derica W RiceDirector | Grant/Award | 638.912 | — | 39,963.721(D) | View → |
| Mar 31, 2026 | Apr 2 8:25 PM | Michael R. McmullenDirector | Grant/Award | 577.082 | — | 15,556.771(D) | View → |
| Mar 31, 2026 | Apr 2 8:24 PM | Peter J ArduiniDirector | Grant/Award | 577.082 | — | 71,435.166(D) | View → |
| Mar 10, 2026 | Mar 12 8:24 PM | Benjamin HickeyPresident, RayzeBio Org. | Grant/Award | 28,572 | — | 17,143(D) | View → |
| Mar 10, 2026 | Mar 12 8:23 PM | Hiroshi Chris ShibutaniEVP, Chief Strategy Officer | Grant/Award | 19,592 | — | 11,755(D) | View → |
| Mar 10, 2026 | Mar 12 8:23 PM | Cristian MassacesiEVP,Chief Med Offr,Head of Dev | Grant/Award | 65,306 | — | 39,184(D) | View → |
| Mar 10, 2026 | Mar 12 8:22 PM | Bartie Wendy ShortEVP, Corporate Affairs | Option Exercise | 5,883 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:22 PM | Bartie Wendy ShortEVP, Corporate Affairs | Grant/Award | 16,327 | — | 9,796(D) | View → |
| Mar 10, 2026 | Mar 12 8:21 PM | Karin ShanahanEVP, Chief Supply Chain & Ops | Option Exercise | 25,501 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:21 PM | Karin ShanahanEVP, Chief Supply Chain & Ops | Grant/Award | 53,061 | — | 31,837(D) | View → |
| Mar 10, 2026 | Mar 12 8:20 PM | Robert M PlengeEVP, Chief Research Officer | Option Exercise | 17,501 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:20 PM | Robert M PlengeEVP, Chief Research Officer | Grant/Award | 44,898 | — | 26,939(D) | View → |
| Mar 10, 2026 | Mar 12 8:19 PM | Gregory Scott MeyersEVP, Chief Digital & Tech Off. | Grant/Award | 65,306 | — | 39,184(D) | View → |
| Mar 10, 2026 | Mar 12 8:19 PM | Gregory Scott MeyersEVP, Chief Digital & Tech Off. | Option Exercise | 25,892 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:18 PM | Adam LenkowskyEVP, Chief Commercial Officer | Option Exercise | 24,071 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:18 PM | Adam LenkowskyEVP, Chief Commercial Officer | Grant/Award | 81,633 | — | 48,980(D) | View → |
| Mar 10, 2026 | Mar 12 8:17 PM | Phil M HolzerSVP and Controller | Option Exercise | 6,191 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:17 PM | Phil M HolzerSVP and Controller | Grant/Award | 12,578 | — | 7,547(D) | View → |
| Mar 10, 2026 | Mar 12 8:17 PM | Lynelle HochPresident, Cell Therapy Org. | Option Exercise | 8,192 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:17 PM | Lynelle HochPresident, Cell Therapy Org. | Grant/Award | 16,327 | — | 9,796(D) | View → |